Indo US Bio-Tech Limited
INDOUS.NS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.28B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.28 Billion |
|---|---|
| Enterprise Value | $1.59 Billion |
| Earnings per Share | $6.54 |
| Beta | 0.25 |
| Outstanding Shares | 20,052,000 |
Return
| Return on Equity | 12.38% |
|---|---|
| Return on Assets | 8.61% |
| Return on Invested Capital | 15.59% |
Valuation & Multiples
| P/E Ratio | 11.19 |
|---|---|
| PEG | -31.61 |
| Price to Sales | 1.55 |
| Price to Book Ratio | 1.89 |
| Enterprise Value to Revenue | 1.41 |
| Enterprise Value to EBIT | 10.92 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.41 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Indo US Bio-Tech Limited
883 employees
CEO: Jagdishkumar Devjibhai Ajudia
Indo US Bio-Tech Limited specializes in the comprehensive lifecycle of agricultural seeds. Its operations span from initial research and development to the production, commercialization, and sale of a wide array of seeds for farming. The...